A new study from Yeshiva University has revealed a surprising finding—some widely used medications for high blood pressure ...
Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...
The Launch-HTN trial evaluated lorundrostat as an add-on therapy to an existing, prescribed background treatment of two-to-five anti-hypertensive medications, while the Advance-HTN trial evaluated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results